Dietary n-3 polyunsaturated fatty acids revert renal responses induced by a combination of 2 protocols that increase the amounts of advanced glycation end product in rats

Nutrition Research

Volumn 35, Issue 6, 2014, Pages 512-522

  De Assis, Adriano M ^a   Rech, Anderson ^a   Longoni, Aline ^a   da Silva Morrone, Maurílio ^a   de Bittencourt Pasquali, Matheus A ^a   Perry, Marcos L S ^a   Souza, Diogo O ^a   Moreira, José C F ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Dietary n 3 polyunsaturated fatty acids; High AGE fat containing diet; Oxidative stress; Proinflammatory status; Renal parameters

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALLOXAN; CATALASE; CREATININE; GLUCOSE; GLUTATHIONE PEROXIDASE; MANGANESE SUPEROXIDE DISMUTASE; OMEGA 3 FATTY ACID; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; TUMOR NECROSIS FACTOR;

ADULT; ALLOXAN-INDUCED DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; KIDNEY METABOLISM; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RENAL PROTECTION; ANIMAL; BLOOD; COMPLICATION; DIABETIC NEPHROPATHIES; DIET; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; METABOLISM; OXIDATIVE STRESS; WISTAR RAT;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIET; FATTY ACIDS, OMEGA-3; GLYCOSYLATION END PRODUCTS, ADVANCED; KIDNEY; MALE; OXIDATIVE STRESS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84945457323     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2015.04.013     Document Type: Article

References (61)

1. Probst-Hensch N.M. Chronic age-related diseases share risk factors: do they share pathophysiological mechanisms and why does that matter?. Swiss Med Wkly 2010, 140:w13072.
2. Libby P. Metformin and vascular protection: a cardiologist's view. Diabetes Metab 2003, 29:6S117-20.
3. Oberg B.P., McMenamin E., Lucas F.L., McMonagle E., Morrow J., Ikizler T.A., et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 2004, 65:1009-1016.
4. Vlassara H., Uribarri J., Ferrucci L., Cai W., Torreggiani M., Post J.B., et al. Identifying advanced glycation end products as a major source of oxidants in aging: implications for the management and/or prevention of reduced renal function in elderly persons. Semin Nephrol 2009, 29:594-603.
5. Koschinsky T., He C.J., Mitsuhashi T., Bucala R., Liu C., Buenting C., et al. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 1997, 94:6474-6479.
6. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
7. Ulrich P., Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001, 56:1-21.
8. Thornalley P.J. The enzymatic defence against glycation in health, disease and therapeutics: a symposium to examine the concept. Biochem Soc Trans 2003, 31:1341-1342.
9. Vlassara H., Cai W., Crandall J., Goldberg T., Oberstein R., Dardaine V., et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 2002, 99:15596-15601.
10. Fujioka K., Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environ Toxicol 2006, 21:47-54.
11. Goldberg T., Cai W., Peppa M., Dardaine V., Baliga B.S., Uribarri J., et al. Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004, 104:1287-1291.
12. Uribarri J., Peppa M., Cai W., Goldberg T., Lu M., He C., et al. Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am Soc Nephrol 2003, 14:728-731.
13. Thornalley P.J. Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 2003, 31:1343-1348.
14. Lauretani F., Maggio M., Pizzarelli F., Michelassi S., Ruggiero C., Ceda G.P., et al. Omega-3 and renal function in older adults. Curr Pharm Des 2009, 15:4149-4156.
15. Goksu Erol A.Y., Avci G., Sevimli A., Ulutas E., Ozdemir M. The protective effects of omega 3 fatty acids and sesame oil against cyclosporine A-induced nephrotoxicity. Drug Chem Toxicol 2013, 36:241-248.
16. Shimizu H., Ohtani K., Tanaka Y., Sato N., Mori M., Shimomura Y. Long-term effect of eicosapentaenoic acid ethyl (EPA-E) on albuminuria of non-insulin dependent diabetic patients. Diabetes Res Clin Pract 1995, 28:35-40.
17. Miller E.R., Juraschek S.P., Anderson C.A., Guallar E., Henoch-Ryugo K., Charleston J., et al. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on biomarkers of kidney injury in adults with diabetes: results of the GO-FISH trial. Diabetes Care 2013, 36:1462-1469.
18. Taneda S., Honda K., Tomidokoro K., Uto K., Nitta K., Oda H. Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. Am J Physiol Renal 2010, 299:F1451-F1461.
19. Kuda O., Jelenik T., Jilkova Z., Flachs P., Rossmeisl M., Hensler M., et al. n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 2009, 52:941-951.
20. Bender N., Portmann M., Heg Z., Hofmann K., Zwahlen M., Egger M. Fish or n3-PUFA intake and body composition: a systematic review and meta-analysis. Obes Rev 2014, 15:657-665.
21. Katakura M., Hashimoto M., Inoue T., Al Mamun A., Tanabe Y., Iwamoto R., et al. Omega-3 fatty acids protect renal functions by increasing docosahexaenoic acid-derived metabolite levels in SHR.Cg-Lepr(cp)/NDmcr rats, a metabolic syndrome model. Molecules 2014, 19:3247-3263.
22. de Assis A.M., Rieger D.K., Longoni A., Battu C., Raymundi S., da Rocha R.F., et al. High fat and highly thermolyzed fat diets promote insulin resistance and increase DNA damage in rats. Exp Biol Med (Maywood) 2009, 234:1296-1304.
23. de Assis A.M., Rech A., Longoni A., Rotta L.N., Denardin C.C., Pasquali M.A., et al. Omega3-polyunsaturated fatty acids prevent lipoperoxidation, modulate antioxidant enzymes, and reduce lipid content but do not alter glycogen metabolism in the livers of diabetic rats fed on a high fat thermolyzed diet. Mol Cell Biochem 2012, 361:151-160.
24. Sandu O., Song K., Cai W., Zheng F., Uribarri J., Vlassara H. Insulin resistance and type 2 diabetes in high-fat-fed mice are linked to high glycotoxin intake. Diabetes 2005, 54:2314-2319.
25. Horwitz W., Kamps L.R., Boyer K.W. Quality assurance in the analysis of foods and trace constituents. J Assoc Off Anal Chem 1980, 63:1344-1354.
26. Lorenzi R., Andrades M.E., Bortolin R.C., Nagai R., Dal-Pizzol F., Moreira J.C. Circulating glycolaldehyde induces oxidative damage in the kidney of rats. Diabetes Res Clin Pract 2010, 89:262-267.
27. Park S., Kim C.S., Lee J., Suk Kim J., Kim J. Effect of regular exercise on the histochemical changes of d-galactose-induced oxidative renal injury in high-fat diet-fed rats. Acta Histochem Cytochem 2013, 46:111-119.
28. Mannervik B., Aronsson A.C., Marmstal E., Tibbelin G. Glyoxalase I (rat liver). Methods Enzymol 1981, 77:297-301.
29. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992, 5:227-231.
30. Levine R.L., Williams J.A., Stadtman E.R., Shacter E. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 1994, 233:346-357.
31. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990, 186:421-431.
32. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
33. Boveris A. Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods Enzymol 1984, 105:429-435.
34. Wendel A. Glutathione peroxidase. Methods Enzymol 1981, 77:325-333.
35. Pasquali M.A.D., de Oliveira M.R., De Bastiani M.A., da Rocha R.F., Schnorr C.E., Gasparotto J., et al. L-NAME co-treatment prevent oxidative damage in the lung of adult Wistar rats treated with vitamin A supplementation. Cell Biochem Funct 2012, 30:256-263.
36. De Oliveira M.R., Oliveira M.W., Behr G.A., Moreira J.C. Vitamin A supplementation at clinical doses induces a dysfunction in the redox and bioenergetics states, but did change neither caspases activities nor TNF-alpha levels in the frontal cortex of adult Wistar rats. J Psychiatr Res 2009, 43:754-762.
37. Brouwers O., Niessen P.M., Miyata T., Ostergaard J.A., Flyvbjerg A., Peutz-Kootstra C.J., et al. Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. Diabetologia 2014, 57:224-235.
38. Pourghasem M., Nasiri E., Shafi H. Early renal histological changes in alloxan-induced diabetic rats. Int J Mol Cell Med 2014, 3:11-15.
39. Sugimoto H., Grahovac G., Zeisberg M., Kalluri R. Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors. Diabetes 2007, 56:1825-1833.
40. Kumar V.L., Padhy B.M. Protective effect of aqueous suspension of dried latex of Calotropis procera against oxidative stress and renal damage in diabetic rats. Biocell 2011, 35:63-69.
41. Bhattacharya S., Manna P., Gachhui R., Sil P.C. d-Saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-kappaB and PKC signaling. Toxicol Appl Pharmacol 2013, 267:16-29.
42. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute Dialysis Quality Initiative workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8:R204-R212.
43. Stevens L.A., Coresh J., Greene T., Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-2483.
44. Busch M., Franke S., Ruster C., Wolf G. Advanced glycation end-products and the kidney. Eur J Clin Investig 2010, 40:742-755.
45. Iacobini C., Menini S., Ricci C., Blasetti Fantauzzi C., Scipioni A., Salvi L., et al. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. J Hepatol 2011, 54:975-983.
46. Huang K., Pai M., Wu C., Liu J., Yeh S. Supplemental dietary arginine reduces renal RAGE expression and oxidative damage in rats with streptozotocin-induced type 2 diabetes. E Spen Eur E J Clin Nutr Metab 2010, 5:77-84.
47. Wei W., Chen M., Zhu Y., Wang J., Zhu P., Li Y., et al. Down-regulation of vascular HMGB1 and RAGE expression by n-3 polyunsaturated fatty acids is accompanied by amelioration of chronic vasculopathy of small bowel allografts. J Nutr Biochem 2012, 23:1333-1340.
48. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84.
49. Scivittaro V., Ganz M.B., Weiss M.F. AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am J Physiol Renal Physiol 2000, 278:F676-F683.
50. An W.S., Kim H.J., Cho K.H., Vaziri N.D. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. Am J Physiol Renal Physiol 2009, 297:F895-F903.
51. Krishan PaC V.A. Diabetic nephropathy: aggressive involvement of oxidative stress. J Pharm Educ Res 2011, 2:35-41.
52. Small D.M., Coombes J.S., Bennett N., Johnson D.W., Gobe G.C. Oxidative stress, anti-oxidant therapies and chronic kidney disease. Nephrology (Carlton) 2012, 17:311-321.
53. Ruggiero C., Ehrenshaft M., Cleland E., Stadler K. High-fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am J Physiol Endocrinol Metab 2011, 300:E1047-E1058.
54. Fujita H., Fujishima H., Chida S., Takahashi K., Qi Z., Kanetsuna Y., et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol 2009, 20:1303-1313.
55. Garman J.H., Mulroney S., Manigrasso M., Flynn E., Maric C. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am J Physiol Renal Physiol 2009, 296:F306-F316.
56. Friedman A.N. Omega-3 fatty acid supplementation in advanced kidney disease. Semin Dial 2010, 23:396-400.
57. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95.
58. Mima A. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets. J Diabetes Res 2013, 2013:248-563.
59. Lange-Sperandio B., Sperandio M., Peter Nawroth P., Bierhaus A. RAGE signaling in cell adhesion and inflammation. Curr Pediatr Rev 2007, 3:1-9.
60. Diaz Encarnacion M.M., Warner G.M., Cheng J., Gray C.E., Nath K.A., Grande J.P. n-3 Fatty acids block TNF-alpha-stimulated MCP-1 expression in rat mesangial cells. Am J Physiol Renal Physiol 2011, 300:F1142-F1151.
61. Londero L.G., Rieger D.K., Hansen F., Silveira S.L., Martins T.L., Lulhier F., et al. Dietary n-3 long-chain polyunsaturated fatty acids modify phosphoenolpyruvate carboxylcinase activity and lipid synthesis from glucose in adipose tissue of rats fed a high-sucrose diet. Cell Biochem Funct 2013, 31:636-642.